Bioventus Inc. (BVS): Shareholders' Equity
$184.10M
As of 2025-12-31
$228.31M
As of 2026-06-27
-17.3%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $184.10M | +24.4% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $147.94M | -14.8% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $173.59M | -46.6% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $325.24M | n/c | 2024-03-12, Balance as of period end |
| 2021-12-31 | $458.92M | n/a | 2023-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Bioventus Inc. (BVS) | 2025-12-31 | $184.10M | +24.4% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $423.88M | +23.7% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $491.94M | +6.7% |
| Glaukos Corp (GKOS) | 2025-12-31 | $656.15M | -14.4% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $340.47M | -5.5% |
| Artivion, Inc. (AORT) | 2025-12-31 | $448.23M | +62.3% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $152.75M | +68.0% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $12.43M | n/m |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $256.55M | +32.9% |
Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗